Targeting the Microenvironment in Advanced Colorectal Cancer

Area of Science:

• Oncology
• Cancer Biology
• Tumor Microenvironment Research

Background:

• Colorectal cancer (CRC) diagnosis frequently occurs at advanced stages, with disseminated tumor cells.
• Metastatic CRC is a leading cause of cancer death, and current therapies are largely ineffective.
• Clinical focus remains on tumor cells, neglecting the tumor microenvironment's role in CRC progression.

Purpose of the Study:

• To review and discuss integrated therapeutic strategies for poor-prognosis colorectal cancer.
• To highlight the significance of the tumor microenvironment and transforming growth factor-beta (TGF-β) in CRC metastasis.
• To propose alternative treatment approaches beyond targeting the epithelial compartment.

Main Methods:

• Literature review and synthesis of current research on CRC progression and metastasis.
• Analysis of the role of the tumor microenvironment, specifically TGF-β-activated stroma.
• Discussion of integrated approaches targeting the tumor ecosystem.

Main Results:

• Disseminated tumor cells in CRC depend on a TGF-β-activated stroma for metastatic colonization and growth.
• The tumor microenvironment is a critical factor in the progression and poor prognosis of CRC.
• Current therapies are insufficient for managing metastatic CRC, necessitating novel strategies.

Conclusions:

• Targeting the tumor microenvironment, particularly TGF-β signaling, is crucial for treating advanced CRC.
• Integrated approaches that address the entire tumor ecosystem are needed for effective CRC therapy.
• Developing new strategies focused on the tumor microenvironment is essential for improving outcomes in metastatic colorectal cancer.